COVID-19: Investigation of existing compounds

We do everything we can to accelerate the development of potential therapies for COVID-19. As part of our efforts, existing compounds from our current pipeline as well as compounds from past research are being tested as potential treatments for patients. 

Investigation of compounds from our pipeline: 
Our researchers are investigating whether existing compounds from our portfolio can be used for the treatment of dangerous lung symptoms experienced by some people infected with COVID-19. 

Investigation of compounds from past research:
In this context, we are investigating whether antiviral molecules, once developed for people living with HIV and hepatitis C, can be used against SARS-CoV2.